RV5 (Pentavalent Rotavirus Vaccine)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Diarrhea
Conditions
Diarrhea, Gastroenteritis
Trial Timeline
Feb 1, 2014 → May 1, 2016
NCT ID
NCT01960725About RV5 (Pentavalent Rotavirus Vaccine)
RV5 (Pentavalent Rotavirus Vaccine) is a approved stage product being developed by Merck for Diarrhea. The current trial status is completed. This product is registered under clinical trial identifier NCT01960725. Target conditions include Diarrhea, Gastroenteritis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01960725 | Approved | Completed |
Competing Products
20 competing products in Diarrhea